Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Latest News

Impact investing – time to capture market potential
Sometimes one bottom line is not enough. Many investors are no longer satisfied simply by turning a profit. More and more also want their investments to generate a positive impact in the world.
New title for a new era – launch of Global…
Global Government Venturing over the past five years has followed the increasing engagement of sovereign wealth funds and states in the innovation capital ecosystem.
Hyperloop One digs into $172m
DP World has returned to lead a $172m funding round for the advanced transport technology developer, having previously co-led a $50m round in 2017.
Rimac rides Hyundai to new funding
Hyundai and subsidiary Kia have provided $93.7m in capital for electric vehicle developer Rimac Automobili through a partnership deal that will involve them collaborating on new models.
Impossible Foods impresses with $300m
Alphabet-backed vegan burger producer Impossible will use the funding, secured at a $2bn valuation, to increase production capacity.
Nabard sows $99m for investment fund
Nabard’s food, agriculture and rural development-focused investment vehicle, Nabventures, has reached its first close and has a ceiling of nearly $100m.
LetsGetChecked sets down $30m series B
The Optum-backed round was led by Leerink Transformation Partners and will fund the home medical test provider's international expansion plans.
Verve Therapeutics pumps in series A funding
GV led a $58.5m round for the heart disease drug developer, which came in the wake of a partnership with another Alphabet subsidiary, Verily.

News Continued

Twentyeight-Seven recalculates series A round
Johnson & Johnson, Novartis and Astellas all took part in the first close of a round for oncology therapy developer 28-7 Therapeutics that now stands at $82.8m.
Milestone Pharmaceuticals progresses to flotation
Milestone, a cardiovascular nasal spray developer that raised more than $167m in VC funding from investors including Novo, secured $82.5m in when it went public.
MGI Tech takes $200m
BGI's gene sequencer spinoff, MGI Tech, has secured $200m in funding from Goldstone Investment, Green Pine Capital and Orient Securities despite a reported $1bn target.
Pfizer feels its way to $340m Therachon acquisition
Therachon, which had raised $100m from investors including Pfizer Ventures and Novo, has agreed to be acquired by Pfizer in a deal that could potentially reach $810m.
DispatchHealth gets $33m funding delivery
Corporate joint venture Echo Health Ventures led a $33m funding round that will help fund the home care access platform's expansion in the US.
Unshackled Ventures unsheathes $20m second fund
Bloomberg has backed Unshackled Ventures, which facilitates the launch of companies by migrants and immigrants in the US, helping it reach a $20m close for its second fund.

Editor's Picks

Impact investing – time to capture market potential
Sometimes one bottom line is not enough. Many investors are no longer satisfied simply by turning a profit. More and more also want their investments to generate a positive impact in the world.
New title for a new era – launch of Global…
Global Government Venturing over the past five years has followed the increasing engagement of sovereign wealth funds and states in the innovation capital ecosystem.
Impossible Foods impresses with $300m
Alphabet-backed vegan burger producer Impossible will use the funding, secured at a $2bn valuation, to increase production capacity.
Unshackled Ventures unsheathes $20m second fund
Bloomberg has backed Unshackled Ventures, which facilitates the launch of companies by migrants and immigrants in the US, helping it reach a $20m close for its second fund.
test reg

Login